beta-Aminoethyl Isothiourea
Showing 1 - 25 of 2,998
Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Interstitial Pneumonitis Trial in Bethesda, Falls Church (Aerobic
Recruiting
- Interstitial Lung Disease
- +3 more
- Aerobic Exercise Training (AET)
- No AET (education only)
-
Bethesda, Maryland
- +1 more
Jan 18, 2023
End-Stage Kidney Disease, End-Stage Renal Disease Trial in Boston, Minneapolis, New York (Metoprolol Succinate, Carvedilol)
Not yet recruiting
- End-Stage Kidney Disease
- End-Stage Renal Disease
- Metoprolol Succinate
- Carvedilol
-
Boston, Massachusetts
- +4 more
Jun 26, 2023
Stable Ischemic Heart Disease, Coronary Artery Disease, Beta-blocker Therapy Trial in Edmonton (Medical Assessment, Quality of
Recruiting
- Stable Ischemic Heart Disease
- +2 more
- Medical Assessment
- Quality of Life Assessment
-
Edmonton, Alberta, CanadaUniversity of Alberta Hospital
Jan 30, 2023
Bone Denisty Change in Children With Beta Thalassemia Major
Not yet recruiting
- Evaluate Bone Denisty Changes in Children With Beta Thalassemia Major
- Dexa scan
- (no location specified)
Sep 29, 2023
Pediatric Hearing Loss Due to OTOF, GJB2, or GJB2/GJB6 Mutations
Not yet recruiting
- Congenital Hearing Loss Secondary to Biallelic Mutations in the Otoferlin Gene (OTOF)
- +2 more
- (no location specified)
Aug 25, 2023
Spleen Stiffness asMeasure to Assess REsponse to ß Blocker
Not yet recruiting
- High Risk Esophageal Varices
- No intervention
-
New Delhi, Delhi, IndiaInstitute of Liver & Biliary Sciences
Sep 16, 2023
Cirrhosis, Liver, Portal Hypertension, Variceal Hemorrhage Trial in London (Carvedilol, Placebo)
Recruiting
- Cirrhosis, Liver
- +3 more
- Carvedilol
- Placebo
-
London, United KingdomKing's College Hospital
May 23, 2023
type1diabetes, Type2diabetes, Pre Diabetes Trial in Parma (68Ga-exendin-4, mixed meal test)
Recruiting
- type1diabetes
- +3 more
- 68Ga-exendin-4
- mixed meal test
-
Parma, Pr, ItalyAzienda Ospedaliero Universitaria di Parma
Dec 20, 2022
Diabetes, Type 2, Obesity Trial in Toronto (Time restricted feeding, Standard lifestyle)
Recruiting
- Diabetes Mellitus, Type 2
- Obesity
- Time restricted feeding
- Standard lifestyle
-
Toronto, Ontario, CanadaLeadership Sinai Centre foe Diabetes - Mount Sinai Hospital
Jan 30, 2023
Type 1 Diabetes Trial in Nijmegen (68Ga-NODAGA-Exendin-4)
Recruiting
- Type 1 Diabetes
-
Nijmegen, Gelderland, NetherlandsRadboud University Medical Center
Nov 17, 2022
Cognitive Function, Fatigue and Health Related Quality of Life
Recruiting
- Cognitive Change
- +3 more
-
Giza, EgyptAbo El-Rish Pediatric Hospital
Jul 20, 2022
Aortic Valve Stenosis Trial (Beta blocker)
Not yet recruiting
- Aortic Valve Stenosis
- Beta blocker
- (no location specified)
Feb 14, 2023
Pancreatic Ductal Adenocarcinoma, Gastroesophageal Adenocarcinoma, Glioblastoma Multiforme Trial (68Ga-FF58, 177Lu-FF58)
Not yet recruiting
- Pancreatic Ductal Adenocarcinoma
- +2 more
- (no location specified)
Jul 28, 2023
Multiple Sclerosis, Relapsing-Remitting Trial in Worldwide (Dimethyl Fumarate, Peginterferon Beta-1a, Placebo)
Terminated
- Multiple Sclerosis, Relapsing-Remitting
- Dimethyl Fumarate
- +2 more
-
Raleigh, North Carolina
- +22 more
Nov 30, 2022
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8
Recruiting
- Advanced Triple-Negative Breast Carcinoma
- +4 more
- Biopsy
- +4 more
-
Birmingham, Alabama
- +9 more
Aug 31, 2022
PreDiabetes, Hyperglycemia Trial in Nottingham, Birmingham (Beta-alanine, Placebo)
Recruiting
- Prediabetes
- +2 more
- Beta-alanine
- Placebo
-
Nottingham, Nottinghamshire, United Kingdom
- +1 more
Dec 19, 2022
Thalassemia, Beta Trial in Karachi (Hydroxyurea and Thalidomide)
Completed
- Thalassemia, Beta
- Hydroxyurea and Thalidomide
-
Karachi, Sindh, PakistanChildren's Hospital Karachi
Nov 23, 2023
Bacterial Infections Trial in Adelaide (QPX2015, Placebo oral capsule)
Completed
- Bacterial Infections
- QPX2015
- Placebo oral capsule
-
Adelaide, South Australia, AustraliaCMAX
Oct 6, 2022
Fabry Disease Trial in Seoul (Fabagal® (Agalsidase beta), Active comparator (Agalsidase beta))
Recruiting
- Fabry Disease
- Fabagal® (Agalsidase beta)
- Active comparator (Agalsidase beta)
-
Seoul, Songpa-gu, Korea, Republic ofSeoul Asan Center
Oct 10, 2023
Exogenous Ketosis Trial in Mexico City (Free Beta-hydroxybutyrate)
Recruiting
- Exogenous Ketosis
- Free Beta-hydroxybutyrate
-
Mexico City, Cdmx, MexicoINCMNSZ
Oct 14, 2022
Hypertension Trial in Dallas (Standard Care, Intensive Treatment)
Active, not recruiting
- Hypertension
- Standard Care
- Intensive Treatment
-
Dallas, TexasUT Southwestern Medical Center
Aug 11, 2022
Fabry Disease Trial in Taipei
Recruiting
- Fabry Disease
-
Taipei, TaiwanInvestigational Site Number :1580001
Sep 24, 2023
Weight Gain Trial in Ancona, Padua (EX_IMF, ST_IMF)
Recruiting
- Weight Gain
- EX_IMF
- ST_IMF
-
Ancona, Italy
- +1 more
Jan 20, 2023
COPD Patients Trial (Beta-glucan supplement group, Placebo group)
Not yet recruiting
- Chronic Obstructive Pulmonary Disease Patients
- Beta-glucan supplement group
- Placebo group
- (no location specified)
May 26, 2023
Motor Cortex, Primary Motor Cortex Trial in Bron (Reach and grasp tasks in healthy participants using MEG technique (Experiment
Recruiting
- Motor Cortex
- Primary Motor Cortex
- Reach and grasp tasks in healthy participants using MEG technique (Experiment 1)
- Reach and grasp tasks in healthy participants using EEG technique (Experiment 2)
-
Bron, FranceInstitut des Sciences Cognitives, Marc Jeannerod, UMR 5229 CNRS
Jan 4, 2023